Yamaha officially announced its transition of its YZR-M1 from the iconic inline-four engine to the V4 configuration for the 2026 MotoGP season.

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis. In ...

Explore the 2026 Yamaha WR125R, a powerful dual-sport bike with a sophisticated motor designed for street and dirt ...

The Kawasaki Brusky is Team Green’s push into the practical scooter market, offering a low-cost 125cc option for riders in ...